Log in

Relevant bibliographies by topics / 159.93-055.2-057.17 (043.2)

Contents

Journal articles

Academic literature on the topic '159.93-055.2-057.17 (043.2)'

Author: Grafiati

Published: 30 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic '159.93-055.2-057.17 (043.2).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "159.93-055.2-057.17 (043.2)"

1

Semenova, Lioubov I., and Allan H. White. "Structural Systematics of Rare Earth Complexes. XIX (Hydrated) 1 : 2 Mononuclear Adducts of Lanthanoid(III) Chlorides with 2,2′-Bipyridine and 1,10-Phenanthroline." Australian Journal of Chemistry 52, no. 6 (1999): 571. http://dx.doi.org/10.1071/ch98052.

Full text

Abstract:

Room-temperature single-crystal X-ray structure determinations are recorded for a number of adducts of hydrated lanthanoid(III) trichlorides with 2,2′-bipyridine (‘bpy’) and 1,10-phenanthroline (‘phen’), crystallized from water, methanol or ethanol solutions, containing mononuclear arrays with 1 : 2 Ln/bpy or phen stoichiometry. LaCl3/phen/H2O(1 : 3 : 9), [(phen)2La(OH2)5]Cl3.phen.4H2O, although of overall 1 : 3 LaCl3/phen stoichiometry, has a lattice phen; it is orthorhombic, Pnna, a 19·947(7), b 16·457(5), c 12·213(2) Å, Z = 4; conventional R on |F| was 0·030 for No 2567 ‘observed’ (I >3σ

APA, Harvard, Vancouver, ISO, and other styles

2

Bowmaker, Graham A., Frances M. M. Hannaway, Peter C. Junk, Aaron M. Lee, Brian W. Skelton, and Allan H. White. "Synthetic, Structural and Vibrational Spectroscopic Studies in Bismuth(III) Halide/N,N′-Aromatic Bidentate Base Systems. V Bismuth(III) Halide/N,N′-Bidentate Ligand (1 : 2) Systems." Australian Journal of Chemistry 51, no. 4 (1998): 331. http://dx.doi.org/10.1071/c97040.

Full text

Abstract:

Syntheses and room-temperature single-crystal X-ray determinations are recorded for a number of adducts of BiX3/N,N′-bidentate 1 : 2 stoichiometry (N,N′-bidentate = 2,2′-bipyridine (bpy) or 1,10-phenanthroline (phen)). BiX3/bpy (1 : 2), X = Br, I, are isomorphous, monoclinic, P21/c, a ≈ 7·5, b ≈ 31, c ≈ 10·3 Å, β ≈ 113°, Z = 4; conventional R on |F| were 0·058, 0·055 for No 1744, 2068 independent ‘observed’ (I > 3σ(I)) reflections. BiCl3/phen (1 : 2) is monoclinic, P21/C, a 9·675(3), b 31·845(7), c 7·756(2) Å, β 109·94(2), Z = 4, R 0·071 for No 2537, while BiBr3/phen (1 : 2), also monoclini

APA, Harvard, Vancouver, ISO, and other styles

3

Bowmaker, Graham A., Frances M. M. Hannaway, Peter C. Junk, Aaron M. Lee, Brian W. Skelton, and Allan H. White. "Synthetic, Structural and Vibrational Spectroscopic Studies in Bismuth(III) Halide/N,N′-Aromatic Bidentate Base Systems. IV Bismuth(III) Halide/N,N′-Bidentate Ligand (1 : 1) Systems." Australian Journal of Chemistry 51, no. 4 (1998): 325. http://dx.doi.org/10.1071/c97039.

Full text

Abstract:

Room-temperature single-crystal X-ray studies are recorded for a number of adducts of BiX3 and N,N′-bidentate ligand (2,2′-bipyridine (bpy) or 1,10-phenanthroline (phen)), devoid of coordinated solvent. BiBr3/bpy/MeCN (1 : 1 : 1) is triclinic P-1, a 12·129(2), b 9·955(4), c 7·748(1) Å, α 73·14(2), β 77·34(1), γ 69·79(2)°, Z = 2; conventional R on |F| was 0·036 for No 2252 independent ‘observed’ (I > 3σ(I)) reflections. The phen analogue is isomorphous, a 11·586(3), b 10·839(6), c 7·769(10) Å, α 73·70(7), β 76·67(7), γ 70·34(4)°, Z = 2, R 0·042 for No 800. BiI3/bpy (1 : 1) is triclinic, P-1,

APA, Harvard, Vancouver, ISO, and other styles

4

Hart, Robert D., Graham A. Bowmaker, John D. Kildea, Eban N. de Silva, Brian W. Skelton та Allan H. White. "Lewis-Base Adducts of Group 11 Metal(I) Compounds. LXIX Syntheses, Spectroscopy and Structural Systematics of Some (Solvated) 1 : 2 Binuclear Adducts of Copper(I) Compounds with Triphenylarsine, [(Ph3As)2Cu(μ-X)2Cu(AsPh3)2], X = Cl, Br, ONO2". Australian Journal of Chemistry 50, № 6 (1997): 604. http://dx.doi.org/10.1071/c96041.

Full text

Abstract:

1 : 2 Adducts of copper(I) chloride and bromide with triphenylarsine have been obtained as chloroform- solvated dimers [(Ph3As)2Cu(µ-X)2Cu(AsPh3)2].2CHCl3, characterized by room-temperature single- crystal X-ray studies, monoclinic C 2/c, a ≈ 21·4, b ≈ 17·9, c ≈ 19·3 Å, β ≈ 92°, Z = 4 dimers, conventional R on F being 0·041 and 0·055 for No 3922 and 3130 independent ‘observed’ (I > 3σ(I)) reflections; the halogen atoms of the dimers are disposed on crystallographic 2 axes, together with the associated hydrogen-bonded pair of disordered chloroform molecules. The structures form an interestin

APA, Harvard, Vancouver, ISO, and other styles

5

Banshodani, Masataka, Hideki Kawanishi, Misaki Moriishi, Sadanori Shintaku, and Shinichiro Tsuchiya. "Impact of Hybrid Therapy Comprising Peritoneal Dialysis and Hemodialysis on Acute Cardiovascular Events." Blood Purification 47, no. 4 (2018): 330–36. http://dx.doi.org/10.1159/000495357.

Full text

Abstract:

Background: The impact of hybrid therapy comprising peritoneal dialysis (PD) and hemodialysis on cardiovascular events in PD patients remains unclear. Objective: We aimed to evaluate the effect of hybrid therapy on cardiovascular events. Methods: A total of 93 PD patients undergoing hybrid therapy for ≥3 years were divided into 2 groups according to left ventricular ejection fraction (LVEF): lower ejection fraction (LEF [n = 29], LVEF < 60%) and normal ejection fraction (NEF [n = 64], LVEF ≥60%). Hospitalization rates and echocardiographic parameters were evaluated. Results: The 1-year hosp

APA, Harvard, Vancouver, ISO, and other styles

6

Sasaki, Koji, Nina Shah, Qaiser Bashir, et al. "Outcome of Patients with Light Chain Multiple Myeloma Compared to IgG/IgA Myeloma after Autologous Stem Cell Transplant." Blood 126, no. 23 (2015): 3194. http://dx.doi.org/10.1182/blood.v126.23.3194.3194.

Full text

Abstract:

Abstract Introduction: High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HCT) is the standard of care for younger patients with newly diagnosed multiple myeloma (MM). In approximately 15% of MM patients the monoclonal (M) spike consists of k or l light chains only as opposed to heavy + light chains. It remains unclear whether light chain (LC) MM has a different prognosis compared to other monoclonal protein subtypes after an auto-HCT. Methods: We retrospectively analyzed 1067 patients with MM who underwent auto-HCT between January 1, 2004 and January 1

APA, Harvard, Vancouver, ISO, and other styles

7

Choueiri, Toni K., Todd Michael Bauer, Jaime R. Merchan, et al. "Updated results from the phase 2 LITESPARK-003 study of belzutifan plus cabozantinib in patients with advanced clear cell renal cell carcinoma (ccRCC)." Journal of Clinical Oncology 43, no. 5_suppl (2025): 549. https://doi.org/10.1200/jco.2025.43.5_suppl.549.

Full text

Abstract:

549 Background: In the phase 2 LITESPARK-003 study (NCT03634540), belzutifan plus cabozantinib showed antitumor activity in patients with advanced ccRCC who were treatment-naive (cohort 1) or previously treated (cohort 2). We present updated results from cohorts 1 and 2 with a median follow-up of 34.4 months and 49.9 months, respectively. Methods: Eligible patients had advanced or metastatic ccRCC and ECOG performance status of 0 or 1. Cohort 1 included patients with no prior systemic therapy. Cohort 2 included patients who had received prior immunotherapy and ≤2 systemic regimens. Starting do

APA, Harvard, Vancouver, ISO, and other styles

8

Sasaki, Koji, Ildefonso Ismael Rodriguez-Rivera, Hagop M. Kantarjian, et al. "Correlation of Lymphocyte Count with Treatment Response to Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase." Blood 124, no. 21 (2014): 4538. http://dx.doi.org/10.1182/blood.v124.21.4538.4538.

Full text

Abstract:

Abstract Background: Total lymphocyte count (TLC) has been shown to correlate with outcomes in patients (pts) with acute leukemia. The clinical correlation to TLC in pts with chronic myeloid leukemia in chronic phase (CML-CP) who were treated with a tyrosine-kinase inhibitor (TKI) is unclear. Methods: Lymphocyte data in pts with newly diagnosed CML-CP who were enrolled in consecutive or parallel clinical trials with front-line imatinib (IM), nilotinib (Nilo), or dasatinib (Dasa) were collected at the time of diagnosis, and 3 and 6 months (M) after the start of TKI. Relative lymphocytrosis (RLC

APA, Harvard, Vancouver, ISO, and other styles

9

Lukyanchik, Yuliya D., Tatyana V. Chernysheva, Elena I. Malinina, et al. "Assessment of the heart rate variability and cardiac biomarkers in young athletes: a cross-sectional study." Almanac of Clinical Medicine 53, no. 1 (2025): 34–42. https://doi.org/10.18786/2072-0505-2025-53-003.

Full text

Abstract:

Background: Active athletic activity can occasionally trigger the development of cardiovascular diseases, especially in highly dynamic sports. Athletes who perform their training in cold climatic conditions are at risk of exhaustion of the functional reserve of the body and the sports-associated overstrain. Aim: To determine the characteristics of heart rate variability (HRV) and cardiac biomarkers in young hockey and football players in the Far North, to search for predictors of pathological myocardial remodeling. Methods: This was an observational cross-sectional study in 160 boys aged 12 to

APA, Harvard, Vancouver, ISO, and other styles

10

von Segesser, L. K., T. Mihaljevic, M. Tönz, B. Leskosek, P. Pei, and M. Turina. "Heparin surface coated hard shell venous reservoirs: experimental evaluation ex vivo." International Journal of Artificial Organs 17, no. 12 (1994): 651–56. http://dx.doi.org/10.1177/039139889401701206.

Full text

Abstract:

The present study was designed for ex vivo evaluation of a heparin coated hard shell venous reservoir in comparison to uncoated control reservoirs. An open chest bovine right heart bypass model (n=9, bodyweight 72 ± 6 kg) with passive blood drainage from the right atrium into the venous reservoir and active retransfusion into the pulmonary artery (roller pump) was selected for this purpose. Clear priming was used for the open perfusion circuit. No heparin was given before or during the evaluation period which was scheduled for 6 hours. Reservoir blood flow was at the beginning 3.5 ± 0.6 I/min

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!